Tesamorelin 10mg

Tesamorelin is a synthetic GHRH analogue, studied within Australian peptide research communities for its interaction with growth hormone-releasing hormone receptor pathways.

Tesa is the common shorthand for Tesamorelin. Both names refer to the same 44-amino-acid GHRH analogue. PhaseOne supplies Tesa peptide in 10mg vials for laboratory research use only.

Egrifta is the brand name under which tesamorelin is supplied as a prescription medicine in some markets. The active compound is the same peptide, but the branded medicine and PhaseOne's research-grade lyophilised powder are different products supplied through entirely different channels.

Egrifta SV and Egrifta WR are reformulations of the same active compound, tesamorelin, differing in their formulation and reconstitution requirements rather than in the peptide itself. Neither is what PhaseOne supplies — we stock tesamorelin as a research-grade lyophilised powder.

Yes — PhaseOne has Tesa peptide for sale online in 10mg vials, shipped Australia-wide. Online results for tesamorelin split into two very different things: research-grade lyophilised powder sold by research suppliers, and the branded prescription medicine Egrifta dispensed through pharmacy channels. PhaseOne supplies the former, with a batch Certificate of Analysis on every vial.

They act at different points on the growth hormone axis. Tesamorelin is a GHRH analogue binding the GHRH receptor, while Ipamorelin is a selective growth hormone secretagogue acting at the ghrelin receptor. The two are often studied alongside each other for that reason. PhaseOne supplies both separately. (!) View our Ipamorelin.

Both are GHRH analogues. Sermorelin corresponds to the first 29 amino acids of GHRH, while Tesamorelin is a stabilised 44-amino-acid chain carrying a trans-3-hexenoyl group that extends its stability. PhaseOne stocks Tesamorelin.

Tesamorelin is a stabilised GHRH analogue, distinct from shorter fragment-based GHRH peptides such as CJC-1295. Compare with our CJC-1295 No DAC.

Both are GHRH analogues, but Tesamorelin is a longer, stabilised 44-amino-acid chain, while CJC-1295 No DAC is a shorter fragment with a different research half-life profile. Compare with our CJC-1295 No DAC or the CJC-1295 + Ipamorelin blend.

PhaseOne ships Tesamorelin Australia-wide for research use, dispatched locally with tracking, in 10mg vials. Every vial carries a batch-specific Certificate of Analysis verifying ≥99% HPLC purity.

PhaseOne prices Tesamorelin at A$127.99 for a 10mg vial, with the batch Certificate of Analysis included at no extra cost. Current pricing is shown on this page.

Chemist Warehouse and other Australian chemists do not stock research-grade tesamorelin. Where tesamorelin is supplied as a prescription medicine it is dispensed under the Egrifta brand through pharmacy channels, which is a different product from the research-grade lyophilised powder PhaseOne supplies.

Unreconstituted Tesamorelin should be stored refrigerated and protected from light, and is commonly reconstituted using bacteriostatic water prior to research preparation. Read our reconstitution guide.

Every batch of Tesamorelin sold across Australia by PhaseOne is independently HPLC tested, with a Certificate of Analysis confirming identity and purity.

HPLC testing refers to High Performance Liquid Chromatography, an analytical method used to confirm peptide identity and purity prior to sale.